Rapid Micro Biosystems, Inc. (RPID)

NASDAQ: RPID · Real-Time Price · USD

1.110

-0.040 (-3.48%)

Sep 16, 2026, 4:00 PM EDT - Market closed

Market Cap	55.68M -58.4%
Revenue (ttm)	35.18M +16.1%
Net Income	-51.20M
EPS	-1.11
Shares Out	50.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	264,996
Open	1.160
Previous Close	1.150
Day's Range	1.110 - 1.180
52-Week Range	1.110 - 4.940
Beta	1.44
Analysts	Strong Buy
Price Target	6.67 (+500.9%)
Earnings Date	Aug 7, 2026

About RPID

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquat... [Read more]

Industry Medical Devices

Sector Healthcare

IPO Date Jul 15, 2021

Employees 171

Stock Exchange NASDAQ

Ticker Symbol RPID

Website https://www.rapidmicrobio.com

Full Company Profile

Financial Performance

In 2025, Rapid Micro Biosystems's revenue was $33.59 million, an increase of 19.74% compared to the previous year's $28.05 million. Losses were -$47.12 million, 0.50% more than in 2024.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for RPID stock is "Strong Buy." The 12-month stock price target is $6.67, which is an increase of 500.90% from the latest price.

Price Target

$6.67

(500.90% upside)

Analyst Consensus: Strong Buy

Stock Forecasts

News

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

LEXINGTON, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation s...

12 days ago - GlobeNewsWire

Rapid Micro Biosystems Earnings Call Transcript: Q2 2026

Second quarter revenue grew 11% year-over-year to $8.1 million, with record consumables and service margins. Full-year guidance is reaffirmed, margin expansion is on track, and the MilliporeSigma partnership is expected to drive further growth.

5 weeks ago - Transcripts

Rapid Micro Biosystems Earnings release: Q2 2026

Rapid Micro Biosystems released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.

5 weeks ago - Filings

Rapid Micro Biosystems Quarterly report: Q2 2026

Rapid Micro Biosystems has published its Q2 2026 quarterly earnings report on August 7, 2026.

5 weeks ago - Filings

Rapid Micro Biosystems reports Q2 EPS (27c), consensus (24c)

Reports Q2 revenue $8.05M, consensus $7.88M. “Our second quarter results reflect continued execution against the strategic and financial priorities we outlined at the beginning of the year,” said Robe...

5 weeks ago - TheFly

Rapid Micro Biosystems backs FY26 revenue view $37M-$41M, consensus $39.3M

Raises FY26 system validation view to at least 27 validations from 25 validations. Spignesi continued, “As we look to the second half of 2026, we remain encouraged by strong customer…

5 weeks ago - TheFly

Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results

Reports second quarter 2026 total revenue of $8.1 million , representing 11% growth compared to the second quarter of 2025 Achieved a significant milestone with the 200th Growth Direct system placed ...

5 weeks ago - GlobeNewsWire

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LEXINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation so...

6 weeks ago - GlobeNewsWire

Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026

LEXINGTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation so...

7 weeks ago - GlobeNewsWire

Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

LEXINGTON, Mass., June 10, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation so...

3 months ago - GlobeNewsWire

Rapid Micro Biosystems price target lowered to $5 from $8 at KeyBanc

KeyBanc lowered the firm’s price target on Rapid Micro Biosystems (RPID) to $5 from $8 and keeps an Overweight rating on the shares. The firm is updating its model to…

3 months ago - TheFly

Rapid Micro Biosystems price target lowered to $7 from $8 at Lake Street

Lake Street lowered the firm’s price target on Rapid Micro Biosystems (RPID) to $7 from $8 and keeps a Buy rating on the shares after the company announced an underwritten…

3 months ago - TheFly

Rapid Micro Biosystems Transcript: AGM 2026

The meeting addressed director elections and auditor ratification, with both proposals approved by shareholders. Voting procedures and governance practices were emphasized, and no questions were raised by stakeholders.

3 months ago - Transcripts

Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering

Bain Capital Life Sciences and Armistice Capital are investing approximately $9.8 million, with the potential of up to approximately $32 million in the event the warrants offered in this offering are ...

4 months ago - GlobeNewsWire

Rapid Micro Biosystems reports Q1 EPS (31c), consensus (25c)

Reports Q1 revenue $8.0M, consensus $7.6M. Cash, cash equivalents, short-term investments, and restricted cash were approximately $23M as of March 31. “Our first quarter results reflect strong and con...

4 months ago - TheFly

Rapid Micro Biosystems Earnings Call Transcript: Q1 2026

Q1 2026 revenue grew 11% year-over-year to $8 million, driven by strong system placements and recurring revenue, with record consumables growth and improved product margins. The company reaffirmed its 2026 revenue guidance and continues to expand globally, especially in Asia-Pacific.

4 months ago - Transcripts